TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells

Meng-Lei Zhu1, James V Partin, Elizabeth M Bruckheimer

  • 1Division of Urology, Department of Surgery, University of Kentucky Medical Center, Lexington, Kentucky 40536, USA.

The Prostate
|January 1, 2008
PubMed
Abstract

Insights

Androgen receptor (AR) status dictates prostate cancer cell sensitivity to transforming growth factor-beta 1 (TGF-beta1) induced apoptosis. This interaction influences the development of androgen-independent prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Transforming growth factor-beta (TGF-beta) and androgens synergistically promote apoptosis in prostate cancer cells.
  • The role of the androgen receptor (AR) in this combined effect requires further investigation.

Purpose of the Study:

  • To investigate the contribution of AR in the combined effects of TGF-beta and dihydrotestosterone (DHT) on apoptosis regulation.
  • To analyze AR- and TGF-beta-mediated transcriptional activity in prostate cancer cells.

Main Methods:

  • Transient transfections and luciferase assays were used to evaluate transcriptional activation in response to TGF-beta and DHT.
  • AR cellular distribution and interaction with Smad4 were assessed in relation to apoptotic response.

Main Results:

  • TGF-beta signaling induced AR-mediated transcriptional activation on androgen-responsive promoters (probasin, PSA).
  • DHT enhanced TGF-beta1-induced transcriptional activity via AR-Smad4 interaction in LNCaP-TbetaRII and PC-3-AR cells.
  • DHT did not enhance TGF-beta-mediated apoptosis in PC-3 AR (wt) cells, indicating AR status is crucial.

Conclusions:

  • AR status determines prostate cancer cell sensitivity to TGF-beta1-induced apoptosis.
  • TGF-beta and AR pathways converge, impacting androgen-independent prostate cancer development.
  • AR status is significant in understanding the emergence of androgen-independent prostate tumors.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...